HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Midline Tract Carcinoma

Midline Tract Carcinoma

Midline tract carcinoma refers to a rare and aggressive type of cancer that primarily affects the midline structures of the body, such as the nasal cavity, sinuses, nasopharynx, and other related areas. Research into this form of carcinoma is crucial due to its propensity for rapid progression and poor prognosis. Scientists are delving into understanding the molecular mechanisms driving its development, as well as exploring targeted therapies to improve treatment outcomes. Advances in genomic sequencing have provided insights into the genetic alterations associated with midline tract carcinoma, paving the way for personalized treatment approaches. Additionally, efforts are underway to enhance early detection methods and develop novel immunotherapies to bolster the immune system's ability to fight against this formidable disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp